Reinventing the Indian pharma business is no longer a choice but an imperative: EY report

Reinventing the Indian pharma business is no longer a choice but an imperative: EY report: As Indian pharma companies prepare to shift from supplying commodities to supplying innovations, technology is altering the way health care is imagined and delivered, according to an EY report

VARINDIA- INDIA'S FRONTLINE IT MAGAZINE

Comments

Popular posts from this blog

OpenAI unveils new o3 and o3 mini models, set for 2024 launch

PhysicsWallah transitions to public entity in preparation for 2025 IPO